Tag Archives: Johnson & Johnson

Johnson & Johnson (NYSE:JNJ) reported fourth-quarter earnings and sales that exceeded analysts’ expectations, driven by strong demand for its cancer treatments and contributions from its recent acquisition of Shockwave Medical. Q4 Highlights Revenue: $22.52 billion, a 5.3% year-over-year increase. Adjusted EPS: $2.04 per share, down 11% YoY but above analysts’ …

Following a tumultuous week, Wall Street was expected to open higher on Monday, with investors looking ahead to a highly anticipated U.S. inflation report due later in the week, which could put the market’s strong comeback this year to the test. On Friday, the major stock indexes finished the week …

Tesla and Netflix’s spring profits have delayed Wall Street’s advance after the two tech-focused businesses who announced their spring profits. Despite better-than-expected profit and revenue, Tesla’s stock fell 9.7%, and analysts think that investors may be worried about the electric vehicle manufacturer’s profitability following price cuts. The summertime shutdown of …

Johnson & Johnson delivered stronger-than-expected Q1 earnings that prompted the healthcare giant to boost its full-year guidance. JNJ reported a Q1 EPS of $2.68 on revenue of $24.7 billion to top the average analyst estimate for EPS of $2.50 on revenue of $23.61B. Sales rose 5.6% year-over-year with pharma revenue …

Johnson & Johnson topped Q2 earnings expectations on Tuesday, but the company stock toppled on its trimmed profit outlook. On today’s stock market, JNJ stock rose fell 1.5% to 171.69, according to observers this could be attributed to the overall strength of the US dollar during Q2. The best performance …

US equities are sharply surging on Tuesday as investors digest another batch of corporate results and earnings. The S&P 500 index gained 2.5%, while the Dow Jones Industrial Average jumped 675 points, or roughly 2.2%. The tech-heavy Nasdaq Composite climbed 2.8%.Johnson & Johnson reported earnings for the period that beat …